跨多个细胞区的全球蛋白形变化是阻塞性多变性心肌病的基础
Zhan Gao1, Kalina J Rossler1, Holden T Rogers2
1Department of Cell and Regenerative Biology (Z.G., K.J.R., T.J.A., Y.Z., Y.G.), University of Wisconsin-Madison.
Circulation. Heart failure
|November 24, 2025
概括
这项研究揭示了超出瘤的广泛的蛋白形变化,超出了缩性心肌病 (HCM) 的范围. 这些发现突出了新的细胞通路和这种复杂的心脏病的潜在治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 蛋白质组学是指蛋白质组学.
- 分子医学是分子医学.
背景情况:
- 超性心肌病变 (HCM) 越来越多地被认为涉及除了肉瘤之外的因素.
- 了解HCM表型的异质性需要新的分析方法.
- 顶向下的蛋白质组学提供了一种精确的方法来研究蛋白质形式和疾病异质性.
研究的目的:
- 研究先进阻塞性多变性心肌病 (HCM) 的全球蛋白质形态景观.
- 为了识别HCM中各个细胞区的蛋白质形式的变化.
- 发现有助于HCM病理生理学的新型决定因素和机制.
主要方法:
- 全球自上而下的蛋白质组学在来自晚期阻塞性HCM患者的心肌样本和不失败的对照进行.
- 使用可光分解表面活性剂 (Azo) 进行序列蛋白质提取,促进了包括膜蛋白在内的各种蛋白质类别的溶解.
- 使用高灵敏度自上而下的质谱法检测和量化蛋白质形式.
主要成果:
- 在HCM组织中检测到大约2000种蛋白形体跨细胞区 (肉质网膜,细胞骨,线粒体,细胞核).
- 与对照组相比,在sarcomeric,细胞骨,线粒体,核体和sarcoplasmic网膜蛋白质形式中观察到显著的变化.
- 在sarcomere,sarcoplasmic网膜和细胞骨架之间发现了显著的蛋白质形式交叉,以及在HCM中减少的化线粒体和乙化核细胞体蛋白质形式.
结论:
- 这项研究提供了迄今为止HCM中最全面的蛋白形状分析.
- 它揭示了超出瘤的途径,有助于HCM病理生理学.
- 通过这些蛋白形变化,可以确定HCM的潜在治疗点.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
378
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
378
01:25Cardiomyopathy I: Introduction and Classification
483
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
483
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
432
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
432
01:29Cardiomyopathy V: Interprofessional Care
316
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
316
01:30Cardiomyopathy II: Dilated Cardiomyopathy
449
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
449